Cargando…

Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell Transplant

Ankyrin repeat domain-containing protein 26- (ANKRD26-) related thrombocytopenia is a rare, autosomal dominant condition caused by ANKRD26 gene mutation. ANKRD26-related thrombocytopenia is characterized by moderate thrombocytopenia with minimal bleeding, normal platelet size, and dysmegakaryopoiesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Husnain, Muhammad, Wang, Trent, Valdes, Maikel, Hoffman, James, Lekakis, Lazaros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589226/ https://www.ncbi.nlm.nih.gov/pubmed/31281687 http://dx.doi.org/10.1155/2019/9357572

Ejemplares similares

Idiopathic Pulmonary Embolism in a case of Severe Family ANKRD26 Thrombocytopenia
por: Guison, Jerome, et al.
Publicado: (2017)

The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy
por: Lekakis, Lazaros J., et al.
Publicado: (2019)

Inherited Thrombocytopenia Caused by Germline ANKRD26 Mutation Should Be Considered in Young Patients With Suspected Myelodysplastic Syndrome
por: Kewan, Tariq, et al.
Publicado: (2020)

Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript
por: Wahlster, Lara, et al.
Publicado: (2021)

C3 glomerulopathy associated to multiple myeloma successfully treated by autologous stem cell transplant
por: Hamzi, M. A., et al.
Publicado: (2017)

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26
por: Perez Botero, J, et al.
Publicado: (2015)

Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma
por: Neuendorff, Nina Rosa, et al.
Publicado: (2023)

Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations
por: Drazer, Michael W., et al.
Publicado: (2022)

Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation
por: Yang, Chen-lu, et al.
Publicado: (2021)

An ANKRD26 nonsense somatic mutation in a female with epidermodysplasia verruciformis (Tree Man Syndrome)
por: Uddin, K. M. Furkan, et al.
Publicado: (2018)

Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
por: Ragon, Brittany Knick, et al.
Publicado: (2023)

Kisspeptin Activates Ankrd 26 Gene Expression in Migrating Embryonic GnRH Neurons
por: Soga, Tomoko, et al.
Publicado: (2016)

TALPID3 and ANKRD26 selectively orchestrate FBF1 localization and cilia gating
por: Yan, Hao, et al.
Publicado: (2020)

ANKRD26 Gene Variant of Uncertain Significance in a Patient With Acute Myeloid Leukemia
por: McCormick, Benjamin J, et al.
Publicado: (2023)

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation
por: Uy, Geoffrey L., et al.
Publicado: (2015)

Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine
por: Shimazu, Yutaka, et al.
Publicado: (2021)

Current status of autologous stem cell transplantation for multiple myeloma
por: Al Hamed, Rama, et al.
Publicado: (2019)

Neuroimaging and Neurocognitive Outcomes in Older Patients with Multiple Myeloma Treated with Chemotherapy and Autologous Stem Cell Transplantation
por: Correa, Denise D., et al.
Publicado: (2023)

Neuroimaging and Neurocognitive Outcomes in Older Patients with Multiple Myeloma Treated with Chemotherapy and Autologous Stem Cell Transplantation
por: Correa, Denise D., et al.
Publicado: (2023)

5’UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia
por: Marconi, Caterina, et al.
Publicado: (2017)

一个伴ANKRD26基因突变的2型血小板减少症家系
Publicado: (2018)

Centriolar distal appendages activate the centrosome‐PIDDosome‐p53 signalling axis via ANKRD26
por: Burigotto, Matteo, et al.
Publicado: (2020)

Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases
por: Vyas, Hrushikesh, et al.
Publicado: (2022)

Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26
por: Homan, Claire C., et al.
Publicado: (2023)

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis
por: Basso-Valentina, Francesca, et al.
Publicado: (2023)

Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation
por: Al-Anazi, Khalid Ahmed
Publicado: (2012)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Tosi, P., et al.
Publicado: (2012)

Outcomes of autologous transplantation for multiple myeloma according to different induction regimens
por: de Queiroz Crusoe, Edvan, et al.
Publicado: (2014)

Complete response after autologous stem cell transplant in multiple myeloma
por: Kumar, Lalit, et al.
Publicado: (2014)

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
por: Al-Mansour, Zeina, et al.
Publicado: (2014)

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma
por: Paquin, Ashley, et al.
Publicado: (2020)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
por: Yarlagadda, Lakshmi, et al.
Publicado: (2021)

Interrupted Identities: Autologous Stem Cell Transplant in Patients With Multiple Myeloma
por: Halpin, Sean N, et al.
Publicado: (2021)

Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia
por: Abdrabou, Ahmed Kotb, et al.
Publicado: (2021)

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
por: Srour, Samer A., et al.
Publicado: (2021)

Successful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT)
por: Sivgin, Serdar, et al.
Publicado: (2013)

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
por: Bergantim, Rui, et al.
Publicado: (2012)

Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma
por: Bhowmik, D., et al.
Publicado: (2017)

Ankrd31 in Sperm and Epididymal Integrity
por: Manfrevola, Francesco, et al.
Publicado: (2021)

Autologous transplant for myeloma: when the old meets the new
por: Gay, Francesca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_27jimuk4j4c0lseldfdvacj69c